Nanopore Electroporation: A New Delivery Method Within the Field of Epigenetic Editing
Small · 2026-05 · 22 (28)
DOI: 10.1002/smll.202513858 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 26.03.2026. Verfasst von Frida Ekstrand und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Solid State Physics and NanoLund, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Electroporation, Nanopores, Gene Editing, Epigenesis, Genetic. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ERC CoG NanoPokers, Swedish Research Council (VR), Novo Nordisk foundation.
Abstract (Originalsprache)
Epigenetic modifications influence gene expression and contribute to type 2 diabetes (T2D), but establishing causality requires targeted modulation of specific genes. CRISPR‐dCas9‐based tools offer this potential, yet β‐cells are notoriously difficult to transfect, and efficient, non‐viral delivery methods are lacking. Here, we developed nanopore‐mediated electroporation to deliver a CRISPR interference (CRISPRi) system to clonal INS1 β‐cells, achieving targeted downregulation of insulin expression. Cells were seeded atop a nanopore substrate with CRISPRi plasmids in solution below. Mild electric pulses generated transient nanoscale pores in the membrane, enabling electrophoretic delivery of plasmids into the cytosol while preserving high cell viability. The CRISPRi system comprised the transcriptional repressor Krueppel‐associated Box Domain (KRAB) fused to an inactive Cas9 (dCas9), guided to the transcription start site of the insulin‐1 gene ( Ins1 ) by a single guide RNA (sgRNA). After transfection, Ins1 expression was significantly reduced, demonstrating effective modulation of gene expression in this difficult‐to‐transfect cell type. This nanopore electroporation approach provides a robust, safe, and efficient platform for delivering CRISPR‐dCas9‐based epigenetic editors in pancreatic β‐cells. By enabling precise gene regulation, it opens avenues for mechanistic studies of epigenetic contributions to T2D and potentially other challenging cell systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Solid State Physics and NanoLund, Lund University, Lund, Sweden.
- Department of Clinical Science in Malmö, Epigenetics and Diabetes Unit, Lund University, Scania University Hospital, Malmö, Sweden.
- Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
- SciLifeLab, Lund University, Lund, Sweden.
ORCID-Profile: Christelle N Prinz
Förderung
- ERC CoG NanoPokers
- Swedish Research Council (VR)
- Novo Nordisk foundation
- Region Skåne
- Strategic Research Area Exodiab
- The Crafoord Foundation
- NanoLund
- The Swedish Diabetes Foundation
Zitieren
APA
Ekstrand, F., Ruhrmann, S., Bacos, K., Bartel, S., Jellema, P., Rots, M. G., Ling, C., & Prinz, C. N. (2026). Nanopore Electroporation: A New Delivery Method Within the Field of Epigenetic Editing. Small, 22(28). https://doi.org/10.1002/smll.202513858
Vancouver
Ekstrand F, Ruhrmann S, Bacos K, Bartel S, Jellema P, Rots MG, et al. Nanopore Electroporation: A New Delivery Method Within the Field of Epigenetic Editing. Small. 2026;22(28). doi:10.1002/smll.202513858
BibTeX
@article{Ekstrand2026,
author = {Ekstrand, Frida and Ruhrmann, Sabrina and Bacos, Karl and Bartel, Sabine and Jellema, Pytrick and Rots, Marianne G and Ling, Charlotte and Prinz, Christelle N},
title = {Nanopore Electroporation: A New Delivery Method Within the Field of Epigenetic Editing},
journal = {Small},
year = {2026},
volume = {22},
number = {28},
doi = {10.1002/smll.202513858}
}
EUVIMED